Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN115260153B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN115260153B reveals high-yield synthesis for EGFR inhibitors. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing globally.